Themis Medicare Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2018 Mar-2017 Mar-2016
Growth matrix (%)        
Revenue growth (3.80) (3.30) (6.80) 15.10
Op profit growth 42.50 (24) (14) 112
EBIT growth 33 (21) (0.20) 54.50
Net profit growth 119 (29) (2) 162
Profitability ratios (%)        
OPM 17.70 11.90 15.10 16.40
EBIT margin 15.30 11.10 13.60 12.70
Net profit margin 12.30 5.39 7.37 7
RoCE 10.90 8.83 12.70 14.30
RoNW 3.52 1.76 3.52 6.11
RoA 2.18 1.07 1.73 1.97
Per share ratios ()        
EPS 27 12.20 17.70 17.50
Dividend per share 1.75 -- -- 1.78
Cash EPS 18 4.23 9.39 5.16
Book value per share 199 184 169 86.90
Valuation ratios        
P/E 8.90 45.50 34.80 20.40
P/CEPS 13.40 132 65.50 69.20
P/B 1.20 3.02 3.65 4.11
EV/EBIDTA 8.05 19.10 17.10 10.10
Payout (%)        
Dividend payout -- -- -- 11.20
Tax payout (12) (0.90) (9.10) (11)
Liquidity ratios        
Debtor days 155 102 80.70 73.10
Inventory days 94.30 85.40 89.90 94.70
Creditor days (66) (62) (66) (89)
Leverage ratios        
Interest coverage (2.40) (2) (2.50) (2.40)
Net debt / equity 0.52 0.43 0.48 1.53
Net debt / op. profit 2.65 2.92 2.25 2.97
Cost breakup ()        
Material costs (31) (34) (33) (38)
Employee costs (22) (21) (18) (16)
Other costs (29) (33) (34) (30)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Revenue 202 210 217 232
yoy growth (%) (3.80) (3.30) (6.80) 15.10
Raw materials (63) (72) (71) (88)
As % of sales 31.30 34.20 32.60 37.70
Employee costs (44) (45) (40) (36)
As % of sales 22 21.30 18.50 15.60
Other costs (58) (68) (73) (70)
As % of sales 29 32.50 33.80 30.30
Operating profit 35.70 25 32.80 38.20
OPM 17.70 11.90 15.10 16.40
Depreciation (8.30) (7.40) (7.50) (12)
Interest expense (13) (12) (12) (12)
Other income 3.46 5.60 4.07 3.19
Profit before tax 18 11.30 17.60 17.10
Taxes (2.10) (0.10) (1.60) (1.90)
Tax rate (12) (0.90) (9.10) (11)
Minorities and other -- 0.06 -- 1.06
Adj. profit 15.90 11.30 16 16.30
Exceptional items -- -- -- --
Net profit 24.80 11.30 16 16.30
yoy growth (%) 119 (29) (2) 162
NPM 12.30 5.39 7.37 7
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Profit before tax 18 11.30 17.60 17.10
Depreciation (8.30) (7.40) (7.50) (12)
Tax paid (2.10) (0.10) (1.60) (1.90)
Working capital 41.30 21.80 2.21 (0.60)
Other operating items -- -- -- --
Operating cashflow 48.90 25.60 10.70 2.70
Capital expenditure (18) (47) (54) 20.20
Free cash flow 30.60 (22) (43) 22.90
Equity raised 234 200 173 98.90
Investments 35 23.90 19.30 2.05
Debt financing/disposal 116 76.20 72.30 143
Dividends paid -- -- -- 1.51
Other items -- -- -- --
Net in cash 415 279 221 268
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 9.19 9.18 9.18 9.04
Preference capital -- -- -- --
Reserves 174 149 160 143
Net worth 183 158 169 152
Minority interest
Debt 99.70 81.80 80 82.40
Deferred tax liabilities (net) 15.50 17.30 20.70 21.30
Total liabilities 298 257 270 256
Fixed assets 124 126 128 133
Intangible assets
Investments 35.50 26.60 24.40 22.90
Deferred tax asset (net) 20.10 23.90 25.50 26.10
Net working capital 114 77.30 84.40 65.80
Inventories 54.60 53.60 49.60 48.40
Inventory Days 98.90 -- 86.40 81.60
Sundry debtors 102 72.90 68.60 48.30
Debtor days 186 -- 120 81.30
Other current assets 23.60 25 22.60 23.40
Sundry creditors (30) (35) (31) (32)
Creditor days 53.70 -- 53.20 53.30
Other current liabilities (37) (39) (26) (23)
Cash 5.29 3.45 6.91 8.62
Total assets 298 257 270 256
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
Gross Sales 155 148 160 174 177
Excise Duty -- -- 2.20 6.39 --
Net Sales 155 148 157 168 177
Other Operating Income -- -- -- -- 2.12
Other Income 9.90 5.34 4.89 5.54 2.71
Total Income 165 153 162 173 182
Total Expenditure ** 133 140 142 145 148
PBIDT 32.20 13.80 20.20 28.20 33.30
Interest 9.47 8.90 9.06 8.94 9.09
PBDT 22.70 4.93 11.10 19.30 24.20
Depreciation 6.20 5.94 5.25 5.29 7.79
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- 1.20
Deferred Tax (1) (1.70) (0.70) (1.50) --
Reported Profit After Tax 17.50 0.66 6.55 15.50 15.20
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 17.50 0.68 6.55 15.50 16.10
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 17.50 0.68 6.55 15.50 16.10
EPS (Unit Curr.) 19.10 0.72 7.15 17.20 18.90
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 9.18 9.18 9.27 9.03 8.51
Public Shareholding (Number) -- -- -- 2,976,005 2,450,005
Public Shareholding (%) -- -- -- 33 28.80
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- 6,055,295 6,055,295
Non Encumbered - % in Total Promoters Holding -- -- -- 100 100
Non Encumbered - % in Total Equity -- -- -- 67.10 71.20
PBIDTM(%) 20.70 9.34 12.80 16.80 18.80
PBDTM(%) 14.60 3.33 7.06 11.50 13.70
PATM(%) 11.30 0.45 4.16 9.26 8.60